Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis
Release Date:
Rupert Leong (University of Sydney) discusses a new double-blind, randomised, placebo-controlled trial of oral faecal microbiota transplantation for patients with active ulcerative colitis.Read the full article:Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS)Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis